Anordrin
Anordrin is a contraceptive agent. Anordrin exhibits estrogenicites and can induce decrease in serum progesterone levels in rat models. Anordrin inhibits endometrial epithelial cell mitosis and NAFLD induced by Tamoxifen in mouse uterus and liver as an anti-estrogenic and estrogenic agent[1][2].
Product Specifications
CAS Number
56470-64-5
UNSPSC
12352211
Target
Progesterone Receptor
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Smiles
C[C@@]12[C@](CC[C@]2(C#C)OC(CC)=O)([H])[C@@]3([H])[C@]([C@@]4([C@@](C[C@](C#C)(C4)OC(CC)=O)([H])CC3)C)([H])CC1
Molecular Formula
C28H38O4
Molecular Weight
438.60
References & Citations
[1]Liu, C. Q., et al., (1985) . Effects of anordrin and its analogue on antifertility. Contraception, 32 (3), 301-309. |[2]Gu, W., et al., (2017) . Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity. Scientific reports, 7, 43940.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15079053 1 Vial
Lentiviral human CARD10 shRNA (UAS) - Lentiviral human CARD10 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
